Old Web
English
Sign In
Acemap
>
authorDetail
>
Polina Binder
Polina Binder
Eli Lilly and Company
Medicine
Internal medicine
Ramucirumab
Meta-analysis
Gastroenterology
4
Papers
11
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Partial Product Aware Machine Learning on DNA-Encoded Libraries.
2022
CoRR
Polina Binder
Neil. Carlson
Svetlana Belyanskaya
Joe Franklin
Henri Palacci
Show All
Source
Cite
Save
Citations (0)
Long-term Treatment with Telotristat Ethyl in Patients with Carcinoid Syndrome Symptoms: Results from the TELEPATH Study.
2021
Neuroendocrinology
Dieter Hörsch
Lowell Anthony
David J. Gross
Juan W. Valle
Staffan Welin
Marta Benavent
Martyn Caplin
Marianne Pavel
Emily K. Bergsland
Kjell Öberg
Kenneth Kassler-Taub
Polina Binder
Phillip Banks
Pablo Lapuerta
Matthew H. Kulke
Show All
Source
Cite
Save
Citations (1)
Ramucirumab Safety in East Asian Patients: A Meta-Analysis of Six Global, Randomized, Double-Blind, Placebo-Controlled, Phase III Clinical Trials
2018
Journal of Global Oncology
Chia-Jui Yen
Kei Muro
Tae-Won Kim
Masatoshi Kudo
Jin-Yuan Shih
Keun Wook Lee
Yee Chao
Sang We Kim
Kentaro Yamazaki
Joo Hyuk Sohn
Rebecca Cheng
Yawei Zhang
Polina Binder
Gu Mi
Mauro Orlando
Hyun Cheol Chung
Show All
Source
Cite
Save
Citations (7)
Comment on: Risk of gastrointestinal perforation in cancer patients receiving ramucirumab: a meta-analysis of randomized controlled trials.
2017
Journal of Chemotherapy
Andreas Sashegyi
Y. Zhang
Yong Lin
Polina Binder
David Ferry
Show All
Source
Cite
Save
Citations (3)
1